Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| hematopoietic stem cell | 7 studies | 65% ± 24% | |
| hematopoietic precursor cell | 6 studies | 52% ± 25% | |
| erythroblast | 4 studies | 25% ± 7% | |
| common myeloid progenitor | 3 studies | 73% ± 15% | |
| granulocyte monocyte progenitor cell | 3 studies | 62% ± 31% | |
| megakaryocyte-erythroid progenitor cell | 3 studies | 62% ± 23% |
Insufficient scRNA-seq data for expression of PRSS57 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| spleen | 100% | 71.46 | 241 / 241 | 0% | 0 | 0 / 0 |
| lung | 94% | 23.17 | 541 / 578 | 4% | 0.13 | 45 / 1155 |
| peripheral blood | 84% | 218.80 | 776 / 929 | 0% | 0 | 0 / 0 |
| ovary | 79% | 12.18 | 143 / 180 | 1% | 0.03 | 5 / 430 |
| adipose | 70% | 5.99 | 844 / 1204 | 0% | 0 | 0 / 0 |
| thymus | 40% | 2.49 | 259 / 653 | 27% | 0.90 | 166 / 605 |
| breast | 64% | 5.42 | 292 / 459 | 2% | 0.05 | 27 / 1118 |
| adrenal gland | 56% | 4.05 | 145 / 258 | 8% | 0.50 | 18 / 230 |
| uterus | 58% | 3.87 | 98 / 170 | 2% | 0.03 | 9 / 459 |
| kidney | 37% | 2.21 | 33 / 89 | 16% | 0.37 | 148 / 901 |
| prostate | 47% | 2.84 | 116 / 245 | 0% | 0.00 | 1 / 502 |
| liver | 46% | 3.85 | 104 / 226 | 1% | 0.03 | 5 / 406 |
| bladder | 43% | 1.62 | 9 / 21 | 2% | 0.07 | 11 / 504 |
| intestine | 40% | 2.37 | 389 / 966 | 2% | 0.06 | 8 / 527 |
| heart | 40% | 2.61 | 342 / 861 | 0% | 0 | 0 / 0 |
| esophagus | 30% | 1.74 | 431 / 1445 | 1% | 0.02 | 1 / 183 |
| stomach | 26% | 1.26 | 92 / 359 | 4% | 0.07 | 12 / 286 |
| skin | 25% | 1.26 | 456 / 1809 | 2% | 0.03 | 9 / 472 |
| blood vessel | 25% | 1.46 | 339 / 1335 | 0% | 0 | 0 / 0 |
| brain | 20% | 1.22 | 541 / 2642 | 0% | 0 | 0 / 705 |
| muscle | 18% | 0.90 | 146 / 803 | 0% | 0 | 0 / 0 |
| pancreas | 11% | 0.43 | 37 / 328 | 2% | 7.76 | 4 / 178 |
| eye | 0% | 0 | 0 / 0 | 8% | 0.17 | 6 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 7% | 0.31 | 3 / 45 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006508 | Biological process | proteolysis |
| GO_0035578 | Cellular component | azurophil granule lumen |
| GO_0005615 | Cellular component | extracellular space |
| GO_0008201 | Molecular function | heparin binding |
| GO_0008236 | Molecular function | serine-type peptidase activity |
| GO_0004252 | Molecular function | serine-type endopeptidase activity |
| Gene name | PRSS57 |
| Protein name | Serine protease 57 Serine protease 57 (EC 3.4.21.-) (Neutrophil serine protease 4) (NSP4) (Serine protease 1-like protein 1) |
| Synonyms | PRSSL1 UNQ782/PRO1599 |
| Description | FUNCTION: Serine protease that cleaves preferentially after Arg residues . Can also cleave after citrulline (deimidated arginine) and methylarginine residues . . |
| Accessions | ENST00000613411.4 ENST00000329267.9 Q6UWY2 A0A0A0MR61 |